Island Pharmaceuticals Ltd
ILPLFDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ISLA101 | Phase 2 | Dengue | - | - |
Frequently asked questions
What is in Island Pharmaceuticals Ltd's drug pipeline?→
CatalystAlert tracks 1 drug candidate in Island Pharmaceuticals Ltd's (ILPLF) pipeline across Phase 2. Its lead program is ISLA101 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Island Pharmaceuticals Ltd's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Island Pharmaceuticals Ltd (ILPLF) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track ILPLF biotech catalysts?→
Add ILPLF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Island Pharmaceuticals Ltd's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.